Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

NCT06367673 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult

Interventions

BIOLOGICAL: iPSC-NK cells

Sponsor

Zhejiang University

Collaborators

[object Object]